Phoenix A. Ho

2.2k citations

29 papers · 1.2k indexed · h-index 15

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 27
- Acute Myeloid Leukemia Research 27
- Hematopoietic Stem Cell Transplantation 6
- Multiple Myeloma Research and Treatments 5
Genetics 6
- Chronic Lymphocytic Leukemia Research 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Co-authors: Soheil Meshinchi Robert B. Gerbing Todd A. Alonzo Susana C. Raimondi Betsy Hirsch Alan S. Gamis Janet Franklin Jessica A. Pollard
Journals: Blood (20 papers)Pediatric Blood & Cancer (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Pancreas (1 paper)
Partner nations: United States Canada Argentina

In The Last Decade

Phoenix A. Ho

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Phoenix A. Ho

Since Specialization

Citations

This map shows the geographic impact of Phoenix A. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phoenix A. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phoenix A. Ho more than expected).

Fields of papers citing papers by Phoenix A. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phoenix A. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phoenix A. Ho. The network helps show where Phoenix A. Ho may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Phoenix A. Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phoenix A. Ho Line = papers co-authored together Phoenix A. Ho links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML Blood ·Amir T. Fathi, Harry P. Erba, Jeffrey E. Lancet, Eytan M. Stein, Farhad Ravandi, Stefan Faderl, Roland B. Walter, Anjali S. Advani, Daniel J. DeAngelo, Tibor Kovacsovics, Anand Jillella, Dale L. Bixby, Moshe Levy, Megan M. O’Meara, Phoenix A. Ho, Jenna L. Voellinger, Anthony S. Stein	2018	55
2	A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia Blood ·Eytan M. Stein, Roland B. Walter, Harry P. Erba, Amir T. Fathi, Anjali S. Advani, Jeffrey E. Lancet, Farhad Ravandi, Tibor Kovacsovics, Daniel J. DeAngelo, Dale L. Bixby, Stefan Faderl, Anand P. Jillella, Phoenix A. Ho, Megan M. O’Meara, Baiteng Zhao, D. Love, Anthony S. Stein	2017	137
3	Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients Haematologica ·Sioḃán Keel, Angela Scott, Marilyn Sánchez-Bonilla, Phoenix A. Ho, Süleyman Gülsüner, Colin C. Pritchard, Janis L. Abkowitz, Mary‐Claire King, Tom Walsh, Akiko Shimamura	2016	107
4	FAM111B Mutation Is Associated With Inherited Exocrine Pancreatic Dysfunction Pancreas ·Hilde ELY-AALSTRUP, Tom Walsh, Ming K. Lee, Phoenix A. Ho, Evelyn Hsu, Robert Sidbury, Mary‐Claire King, Akiko Shimamura	2015	27
5	A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114) Blood ·C. Michel Zwaan, Stefan Söderhäll, Benoît Brethon, Matteo Luciani, Carmelo Rizzari, David Sternberg, Amir Dashti, Catherine Dutreix, Franca Fagioli, Phoenix A. Ho, Carlo Dufour, Rob Pieters	2015	6
6	High EVI 1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group British Journal of Haematology ·Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica A. Pollard, Betsy Hirsch, Susana C. Raimondi, Todd M. Cooper, Alan S. Gamis, Soheil Meshinchi	2013	32
7	Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report Blood ·Todd A. Alonzo, Robert B. Gerbing, Samir B. Kahwash, Amy Heerema‐McKenney, Richard Aplenc, Lillian Sung, Laura Winter, Kathleen Glick, С. А. Шкиль, Stella M. Davies, Patti Byron, Robert S. Lavey, Franklin O. Smith, Phoenix A. Ho, Alan S. Gamis, Soheil Meshinchi, Susana C. Raimondi	2013	9
8	Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group Blood ·Michael R. Loken, Todd A. Alonzo, Laura Pardo, Robert B. Gerbing, Susana C. Raimondi, Betsy Hirsch, Phoenix A. Ho, Janet Franklin, Todd M. Cooper, Alan S. Gamis, Soheil Meshinchi	2012	183
9	WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group Blood ·Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Lillian Sung, Richard Aplenc, Jessica A. Pollard, Julia Kühn, Nyla A. Heerema, Beverly J. Lange, Alan S. Gamis, Soheil Meshinchi	2012	1
10	Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML Blood ·Jessica A. Pollard, Todd A. Alonzo, Michael R. Loken, Robert B. Gerbing, Phoenix A. Ho, Irwin D. Bernstein, Susana C. Raimondi, Betsy Hirsch, Janet Franklin, Roland B. Walter, Alan S. Gamis, Soheil Meshinchi	2012	79
11	Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group Pediatric Blood & Cancer ·Phoenix A. Ho, Matthew A. Kutny, Todd A. Alonzo, Robert B. Gerbing, N I Patyka, Susana C. Raimondi, Alan S. Gamis, Soheil Meshinchi	2011	80
12	Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG, Blood ·Phoenix A. Ho, Megan Othus, Fabiana Ostronoff, Stephen H. Petersdorf, Jeanne E. Anderson, John E. Godwin, Cheryl L. Willman, Jerald P. Radich, Frederick R. Appelbaum, Derek L. Stirewalt, Soheil Meshinchi	2011	1
13	Conventional Cytogenetics, Molecular Profiling, and Flow Cytometric Response Data Allow the Creation of a Two-Tiered Risk-Group System for Risk-Based Therapy Allocation In Childhood AML- a Report From the Children's Oncology Group Blood ·Todd A. Alonzo, Phoenix A. Ho, Robert B. Gerbing, Alan S. Gamis, Susana C. Raimondi, Betsy Hirsch, Todd M. Cooper, Janet Franklin, Laura Pardo, Michael R. Loken, Soheil Meshinchi	2010	6
14	Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group Blood ·Phoenix A. Ho, Rong Zeng, Todd A. Alonzo, Robert B. Gerbing, Kristen L. Miller, Jessica A. Pollard, Derek L. Stirewalt, Nyla A. Heerema, Susana C. Raimondi, Betsy Hirsch, Janet Franklin, Beverly J. Lange, Soheil Meshinchi	2010	66
15	WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group Journal of Clinical Oncology ·Phoenix A. Ho, Julia Kühn, Robert B. Gerbing, Jessica A. Pollard, Rong Zeng, Kristen L. Miller, Nyla A. Heerema, Susana C. Raimondi, Betsy Hirsch, Janet Franklin, Beverly J. Lange, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi	2010	50
16	C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations Blood ·John Anto Pulikkan, Philomina Sona Peramangalam, Viola Dengler, Phoenix A. Ho, Claude Preudhomme, Soheil Meshinchi, Maximilian Christopeit, Olivier Nibourel, Carsten Müller‐Tidow, Stefan K. Bohlander, Daniel G. Tenen, Gerhard Behre	2010	104
17	Identification of Post-Induction Minimal Residual Disease by Multidimensional Flow Cytometry Identifies Patients with AML at High Risk of Relapse and Poor Outcome- a Report From the Children's Oncology Group Blood ·Soheil Meshinchi, Todd A. Alonzo, Robert B. Gerbing, Phoenix A. Ho, Alan S. Gamis, Susana C. Raimondi, Betsy Hirsch, Todd M. Cooper, Janet Franklin, Laura Pardo, Michael R. Loken	2010	1
18	Prevalence and Clinical Implications of N-RAS Mutations in Childhood AML – A Report From the Children's Oncology Group. Blood ·Jason N. Berman, Robert B. Gerbing, Lillian Sung, Kristen L. Miller, Jessica A. Pollard, Phoenix A. Ho, Derek L. Stirewalt, Jerald P. Radich, Craig A. Hurwitz, Nyla A. Heerema, Betsy Hirsch, Susana C. Raimondi, Beverly J. Lange, Alan S. Gamis, Janet Franklin, Todd A. Alonzo, Soheil Meshinchi	2009	1
19	Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group Blood ·Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica A. Pollard, Derek L. Stirewalt, Craig A. Hurwitz, Nyla A. Heerema, Betsy Hirsch, Susana C. Raimondi, Beverly J. Lange, Janet Franklin, Jerald P. Radich, Soheil Meshinchi	2009	135
20	Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML A: Report from Children’s Oncology Group Blood ·Jessica A. Pollard, Rong Zeng, Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Derek L. Stirewalt, Nyla A. Heerema, Susana C. Raimondi, Betsy Hirsch, Janet Franklin, Beverly J. Lange, Soheil Meshinchi	2008	8

About Phoenix A. Ho

Phoenix A. Ho is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Molecular Biology and Cancer Research, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (11 papers), Hematopoietic Stem Cell Transplantation (6 papers), Multiple Myeloma Research and Treatments (5 papers), Renal and related cancers (5 papers), Protein Degradation and Inhibitors (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (876 citations), Genetics (149 citations), Public Health, Environmental and Occupational Health (351 citations), Cancer Research (176 citations) and Oncology (259 citations). Phoenix A. Ho has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Soheil Meshinchi, Robert B. Gerbing, Todd A. Alonzo, Susana C. Raimondi, Betsy Hirsch, Alan S. Gamis, Janet Franklin, Jessica A. Pollard, Michael R. Loken and Todd M. Cooper. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Journal of Clinical Oncology, British Journal of Haematology and Pancreas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact